BANK OF AMERICA CORP /DE/ - CORVUS PHARMACEUTICALS INC ownership

CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 65 filers reported holding CORVUS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.87 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of CORVUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,631
-60.2%
3,172
-37.5%
0.00%
Q2 2023$11,631
+19285.0%
5,079
+7155.7%
0.00%
Q4 2022$6070
-72.4%
0.00%
Q3 2022$0254
-45.1%
0.00%
Q2 2022$0
-100.0%
463
-69.7%
0.00%
Q1 2022$2,000
-66.7%
1,530
-34.3%
0.00%
Q4 2021$6,0002,328
+2430.4%
0.00%
Q2 2021$0
-100.0%
92
-99.1%
0.00%
Q1 2021$31,000
+287.5%
9,936
+174.6%
0.00%
Q1 2020$8,000
-93.5%
3,619
-84.1%
0.00%
Q4 2019$124,000
-13.3%
22,811
-51.9%
0.00%
Q3 2019$143,000
-51.2%
47,427
-39.4%
0.00%
Q2 2019$293,000
+2.1%
78,248
+9.3%
0.00%
Q1 2019$287,000
-2.4%
71,583
-10.8%
0.00%
Q4 2018$294,000
-43.7%
80,281
+32.0%
0.00%
Q3 2018$522,000
-12.0%
60,830
+12.6%
0.00%
Q2 2018$593,000
-2.3%
54,017
+2.6%
0.00%
Q1 2018$607,000
+668.4%
52,659
+584.9%
0.00%
Q4 2017$79,000
+1216.7%
7,689
+1866.5%
0.00%
Q3 2017$6,000391
+39000.0%
0.00%
Q2 2017$0
-100.0%
1
-100.0%
0.00%
Q1 2017$58,000
+41.5%
2,782
-2.9%
0.00%
Q4 2016$41,000
+5.1%
2,864
+22.7%
0.00%
Q3 2016$39,000
+21.9%
2,334
+3.3%
0.00%
Q2 2016$32,0002,2590.00%
Other shareholders
CORVUS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 3,749,379$18,147,0003.77%
VR Adviser, LLC 3,427,461$16,589,0002.13%
ADAMS STREET PARTNERS LLC 3,275,616$15,854,0002.04%
Telemetry Investments, L.L.C. 196,168$949,0001.28%
DC Investments Management, LLC 50,709$245,0000.46%
Orbimed Advisors 6,943,654$33,607,0000.37%
EcoR1 Capital, LLC 2,081,077$10,072,0000.35%
BVF INC/IL 1,370,947$6,635,0000.26%
Ikarian Capital, LLC 757,545$3,666,0000.26%
CHI Advisors LLC 165,927$803,0000.23%
View complete list of CORVUS PHARMACEUTICALS INC shareholders